跳至主要内容
临床试验/CTRI/2024/02/062753
CTRI/2024/02/062753尚未招募Phase 3 4

Evaluation of efficacy and acceptability of herbal toothpaste in the reduction of plaque and gingival inflammation in healthy adult population – A Multicentric pilot study.

Dabur Research & Development Centre5 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年2月26日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
300
试验地点
5
主要终点
Changes in the Plaque and Gingival scores

研究概览

简要总结

The study is an open-label multi-centric clinical trial conducted across 5 centers across India. Total sample size of the study is 300. The study aims to assess the efficacy and efficiency of the toothpaste in its antiplaque and anti-gingivitis properties and to evaluate the acceptability, tolerability, and safety of the toothpaste among the adult population.  

The primary outcome of the study is changes in the plaque and gingival scores and changes in the clinical signs of gingiva inflammation. The secondary outcome is the assessment of its acceptability and tolerability through survey data points.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
12.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Subjects with plaque scores above 1 Subjects with gingival scores between 1 and 2 Subjects showing signs of mild marginal gingival inflammation.

排除标准

  • Subjects with gingival scores more than 2 Subjects with a known history or present condition of hypersensitivity to any toothpaste, The use of antibiotics, antimicrobial, analgesic medications, mouthwash, or desensitizing toothpaste during the previous one month, Any history of periodontal therapy by surgical interventions, History of dentine hypersensitivity treatment History of smoking or smokless tobacco products Subjects who are pregnant, lactating or nursing Subjects with severe calculus or tartar Subjects with uncontrolled medical illness like HIV, hepatitis etc.

结局指标

主要结局

Changes in the Plaque and Gingival scores

时间窗: Plaque and gingival score to be assessed at 1 | monthi.e at 1st followup 2 months i.e at2nd | followup and 3 months i.e at 3rd followup

Changes in the clinical signs of marginal gingival inflammation

时间窗: Plaque and gingival score to be assessed at 1 | monthi.e at 1st followup 2 months i.e at2nd | followup and 3 months i.e at 3rd followup

次要结局

  • Understanding of the products acceptability through survey data points(acceptability and tolerability to be assessed after)

研究者

发起方
Dabur Research & Development Centre
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Ashok Dhoble

Indian Dental Association

研究点 (5)

Loading locations...

相似试验